Patent Term Extension Application for JASCAYD (nerandomilast tablets), Patent No. 9,802,954 | Federal Regulations · Congress.wiki

Nonrulemaking

FDA

FDA-2026-E-1006

Patent Term Extension Application for JASCAYD (nerandomilast tablets), Patent No. 9,802,954

Documents

Comments

Description

OPEN

Comment Period OpensFeb 2, 2026

Type	Title	Posted	Comments	Status
Other	Letter to U.S. Patent and Trademark Office	Apr 20, 2026	--

CDER

Patent Term Extension Application

Boehringer Ingelheim USA Corporation

Boehringer Ingelheim International GmbH

JASCAYD (nerandomilast tablets)

Patent No. 9,802,954

OPEN